Intuitive Surgical (ISRG) Earnings Analysis
Intuitive Surgical (ISRG) next reports earnings on 2026-10-20, consensus EPS 2.59 USD. Last quarter (2026-07-16) it beat with EPS 2.8 USD vs 2.48 USD est (+12.9%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 38.50.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ISRG next report earnings?
| Next earnings date | 2026-10-20 |
|---|---|
| Consensus EPS estimate | 2.59 USD |
| Revenue estimate | 2.90B |
ISRG earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-16 | 2.8 USD | 2.48 USD | +12.9% | Beat |
| 2026-01-22 | 2.53 USD | 2.27 USD | +11.5% | Beat |
| 2025-10-21 | 2.4 USD | 1.99 USD | +20.6% | Beat |
| 2025-07-22 | 2.19 USD | 1.93 USD | +13.5% | Beat |
| 2025-01-23 | 2.21 USD | 1.76 USD | +25.6% | Beat |
| 2024-10-17 | 1.84 USD | 1.63 USD | +12.9% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
ISRG valuation and analyst view
| Trailing P/E | 38.50 |
|---|---|
| Trailing EPS | 8.854 USD |
| Price / book | 6.65 |
| Dividend yield | 0.00% |
| Market cap | 121.11B |
| Analyst consensus | Buy (39 buy / 12 hold / 5 sell) |
| Avg price target | 511.24 USD |
Related research pages
Frequently asked questions
When is Intuitive Surgical (ISRG)'s next earnings date?
Intuitive Surgical is next scheduled to report on 2026-10-20, with a consensus EPS estimate of 2.59 USD and revenue estimate of 2.90B.
Did ISRG beat earnings last quarter?
In its 2026-07-16 report, ISRG posted EPS of 2.8 USD versus a 2.48 USD estimate — a beat of 12.9%.
What is ISRG's earnings track record?
Over the last 6 reported quarters with consensus data, ISRG beat estimates 6 times (100%).
What is ISRG's current P/E ratio and EPS?
ISRG trades at a trailing P/E of 38.50 on trailing EPS of 8.854160789844851 USD.
What do analysts rate ISRG?
Analyst consensus is "Buy" across 56 ratings (0 strong buy, 39 buy, 12 hold, 5 sell, 0 strong sell). Average 12-month price target: 511.24 USD.